|
US6277975B1
(en)
|
1992-10-23 |
2001-08-21 |
Genetics Institute, Inc. |
Fusions of P-selectin ligand protein and polynucleotides encoding same
|
|
US7223845B2
(en)
|
1998-06-16 |
2007-05-29 |
The Board Of Regents Of The University Of Oklahoma |
Synthetic glycosulfopeptides and methods of synthesis thereof
|
|
US20030143662A1
(en)
|
1998-06-16 |
2003-07-31 |
Cummings Richard D. |
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
|
|
AU773542B2
(en)
|
1998-06-16 |
2004-05-27 |
Board Of Regents Of The University Of Oklahoma, The |
Glycosulfopeptides and methods of synthesis and use thereof
|
|
NZ528610A
(en)
*
|
1998-10-30 |
2005-03-24 |
Inst Genetics Llc |
Inhibition of differentiation of cytotoxic T-cells by P-selectin ligand (PSGL) antagonists
|
|
EP1131334A4
(en)
*
|
1998-11-21 |
2003-05-21 |
Univ California |
Use of core 2 glcnac transferase inhibitors in treating inflammation
|
|
US6492152B1
(en)
|
1999-06-15 |
2002-12-10 |
The Board Of Regents Of The University Of Oklahoma |
Core 1 β3-galactosyl transferases and methods of use thereof
|
|
US7256171B1
(en)
|
1999-11-20 |
2007-08-14 |
The Regents Of The University Of California |
Use of core 2 G1cNAc transferase inhibitors in treating inflammation
|
|
AU2000274809A1
(en)
*
|
2000-09-12 |
2002-03-26 |
Genetics Institute Llc |
Inhibition of stenosis or restenosis by p-selectin antagonists
|
|
JP2005503756A
(ja)
*
|
2000-12-29 |
2005-02-10 |
サビエント ファーマシューティカルズ，インコーポレイティド |
硫酸化部分を含むエピトープを含む単離分子、当該エピトープに対する抗体、及びその使用
|
|
US7744888B2
(en)
|
2001-08-03 |
2010-06-29 |
Abgenomics Cooperatief U.A. |
Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
|
|
US20040116333A1
(en)
|
2001-08-03 |
2004-06-17 |
Rong-Hwa Lin |
Modulators of P-selectin glycoprotein ligand 1
|
|
AU2003255337A1
(en)
*
|
2002-07-31 |
2004-02-23 |
Kylix B.V. |
Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
|
|
JP4599027B2
(ja)
*
|
2002-10-30 |
2010-12-15 |
東洋水産株式会社 |
Ｌ−セレクチン結合阻害剤
|
|
FI20021989A0
(fi)
*
|
2002-11-06 |
2002-11-06 |
Halina Miller-Podraza |
Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
|
|
US20080182801A1
(en)
|
2003-12-22 |
2008-07-31 |
Btg International Limited |
Core 2 glcnac-t inhibitors
|
|
GB0513881D0
(en)
|
2005-07-06 |
2005-08-10 |
Btg Int Ltd |
Core 2 GLCNAC-T Inhibitors III
|
|
GB0329667D0
(en)
|
2003-12-22 |
2004-01-28 |
King S College London |
Core 2 GlcNAc-T inhibitor
|
|
UY28886A1
(es)
|
2004-05-10 |
2005-12-30 |
Boehringer Ingelheim Int |
Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
|
|
BRPI0510561A
(pt)
|
2004-05-11 |
2007-11-20 |
Abgenomics Corp |
epìtopos que induzem morte de célula t
|
|
GB0513883D0
(en)
|
2005-07-06 |
2005-08-10 |
Btg Int Ltd |
Diagnosis of Atherosclerosis
|
|
GB0513888D0
(en)
|
2005-07-06 |
2005-08-10 |
Btg Int Ltd |
Core 2 GLCNAC-T Inhibitors II
|
|
WO2007067983A2
(en)
*
|
2005-12-09 |
2007-06-14 |
Wyeth |
Sulfotyrosine specific antibodies and uses therefor
|
|
JP5331293B2
(ja)
*
|
2006-04-28 |
2013-10-30 |
公益財団法人野口研究所 |
多様性を表現するオリゴ糖またはその誘導体
|
|
RU2520105C2
(ru)
*
|
2008-09-02 |
2014-06-20 |
Констракшн Рисёрч Энд Текнолоджи Гмбх |
Содержащая пластифицирующую добавку композиция добавки-ускорителя твердения
|
|
EP2494980A3
(en)
*
|
2009-10-21 |
2013-03-13 |
ETH Zurich |
Medical utility of glycans
|
|
CN116063522A
(zh)
|
2011-06-13 |
2023-05-05 |
美国全心医药生技股份有限公司 |
抗psgl-1抗体及其用途
|
|
JP7244422B2
(ja)
|
2017-01-11 |
2023-03-22 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｐｓｇｌ－１アンタゴニスト及びその使用
|
|
SG11201907848YA
(en)
|
2017-03-14 |
2019-09-27 |
Five Prime Therapeutics Inc |
Antibodies binding to vista at acidic ph
|
|
MX2020009786A
(es)
|
2018-03-21 |
2020-10-12 |
Five Prime Therapeutics Inc |
Anticuerpos de union a supresor de la activacion de celulas t que contiene el dominio variable de inmunoglobulina (vista) a ph acido.
|
|
US12091462B2
(en)
|
2018-07-11 |
2024-09-17 |
Five Prime Therapeutics, Inc. |
Antibodies binding to vista at acidic pH
|